A Llorente, MT Blasco, I Espuny, M Guiu, C Ballaré… - Nature Cell …, 2023 - nature.com
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor …
Lysine-specific histone demethylase 1 (LSD1), which demethylates mono-or di-methylated histone H3 on lysine 4 (H3K4me1/2), is essential for early embryogenesis and development …
LD Caeiro, Y Nakata, RL Borges, M Zha… - Genes & …, 2024 - genesdev.cshlp.org
Approximately 20% of head and neck squamous cell carcinomas (HNSCCs) exhibit reduced methylation on lysine 36 of histone H3 (H3K36me) due to mutations in histone methylase …
B Liu, Y Liu, S Yang, J Ye, J Hu, S Chen, S Wu, Q Liu… - Cancer Letters, 2024 - Elsevier
Acquired resistance to endocrine treatments remains a major clinical challenge. In this study, we found that desmoglein-2 (DSG2) plays a major role in acquired endocrine …
G Zhang, M Dong, X Yao, Y Xia, H Yu, Y Zhou… - Scientific Reports, 2023 - nature.com
Molecular-genetic imaging has greatly advanced clinical diagnosis and prognosis monitoring. However, the specific visualization of intracellular proteins such as estrogen …
L Dong, J Zhu, A Deng, J Wei, J Li, X Mao… - Frontiers in …, 2023 - frontiersin.org
Objective to elucidate the correlation between histone demethylase and gastric cancer Research object histone demethylase and gastric cancer Results As one of the important …
R Zheng, Y Pan, X Liu, F Liu, A Li, D Zheng… - Frontiers in Cell and …, 2023 - frontiersin.org
REST corepressors (RCOR s) are the core component of the LSD1/CoREST/HDACs transcriptional repressor complex, which have been revealed differently expressed in …
In mammals, the histone deacetylase enzymes (HDACs: EC 3.5. 1.98) do catalyze the cleavage of acetyl-lysine residues on proteins of structural and epigenetic meaning and thus …
C Liu, Z Dong, M Li, G Bai, Z Zhao - International Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Objectives: Prostate cancer holds the second-highest incidence rate among all male malignancies, with a noticeable scarcity of effective treatment approaches. The REST …